TABLE 4

Tissue Weighting Factors and Dose Coefficients for 18F-FDG PET (ΓTFDG) and Whole-Body CT (ΓTCT) Scans

Organ TwT*ΓTFDG (μGy/MBq)wT · ΓTFDG (μSv/MBq)ΓTCTwT · ΓTCT (mSv/mGy)
Gonads§0.2013.52.701.41 ± 0.060.28 ± 0.01
Red bone marrow0.12111.321.28 ± 0.040.153 ± 0.005
Colon0.12131.561.53 ± 0.050.184 ± 0.007
Lungs0.12101.201.45 ± 0.070.174 ± 0.009
Stomach0.12111.321.45 ± 0.060.174 ± 0.007
Bladder0.051608.001.38 ± 0.070.069 ± 0.003
Breast0.056.80.341.44 ± 0.080.072 ± 0.004
Liver0.05110.551.58 ± 0.070.079 ± 0.003
Esophagus0.05110.551.43 ± 0.070.072 ± 0.003
Thyroid0.05100.502.4 ± 0.10.123 ± 0.006
Skin0.0180.080.66 ± 0.030.007 ± 0.001
Bone surfaces0.01110.110.86 ± 0.030.009 ± 0.001
Remaining organs0.05110.551.37 ± 0.050.069 ± 0.002
Uterus211.11 ± 0.04
Total191.47 ± 0.02
  • * Tissue weighting factors from ICRP Publication 60 (12).

  • Dose coefficients from ICRP Publication 80 (11).

  • Mean ± SEM.

  • § Since testes were not in the body region scanned in CT, absorbed doses to gonads were defined as that to ovaries.

  • Although the uterus belongs to the remaining organs, dose coefficients are also given for this organ because uterine dose is often used as surrogate for embryonic dose in the early stage of pregnancy.

  • Dose coefficients for CT were estimated according to Equation 2 from TLD measurements performed on Alderson phantom.